PharmChem, Inc.

    PharmChem, Inc.

    OOTC:PCHM
    3.75
    USD
    +0.01
    (+0.27%)
    0.18P/E
    1990 Y
    1991 Y
    1992 Y
    1993 Y
    1994 Y
    1995 Y
    1996 Y
    1997 Y
    1998 Y
    1999 Y
    2000 Y
    2001 Y
    2002 Y
    TTM
    Revenue per Share
    3.49
    4.68
    4.65
    5.21
    6.72
    7.07
    7.23
    6.63
    7.92
    7.69
    6.77
    6.25
    5.14
    4.72
    Basic EPS, GAAP
    0.09
    0.33
    0.39
    -0.7
    0.02
    -1.23
    0.01
    -0.22
    0.11
    0.48
    0.23
    -1.45
    0.57
    -0.17
    Free Cash Flow per Basic Share
    0.09
    0.23
    0.44
    -0.31
    0.02
    0.34
    - -
    -0.25
    0.31
    0.07
    -0.15
    -1.71
    -0.04
    -0.22
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -0.23
    0.14
    0.49
    -0.16
    -0.18
    -1.39
    1.98
    4.73
    1.98
    2.36
    -0.7
    -2.15
    -1.58
    -1.75
    Tangible Book Value per Share
    1.13
    3.98
    2.2
    1.78
    2.4
    1.36
    1.39
    1.17
    1.45
    1.88
    2.13
    1.03
    1.65
    1.47
    Basic Weighted Avg Shares
    4
    5
    6
    6
    5
    6
    6
    6
    5
    6
    6
    6
    6
    6
    Sales/Revenue/Turnover
    16
    24
    27
    29
    34
    39
    41
    39
    43
    44
    39
    37
    30
    28
    Operating Margin (%)
    9.68
    15.35
    13.5
    -1.38
    1.49
    1.28
    1.01
    -2.55
    2.78
    6.19
    2.02
    -22.15
    -2.6
    -4.05
    Depreciation Expense
    -1
    -1
    -1
    -2
    -3
    -3
    2
    -2
    -2
    2
    2
    2
    2
    2
    Net Income, GAAP
    - -
    2
    2
    -4
    - -
    -7
    - -
    -1
    1
    3
    1
    -8
    3
    -1
    Effective Tax Rate (%)
    50
    39.29
    37.84
    - -
    50
    - -
    - -
    - -
    33.33
    - -
    47.31
    - -
    - -
    - -
    Profit Margin (%)
    2.58
    7.05
    8.39
    -13.45
    0.3
    -17.39
    0.11
    -3.32
    1.39
    6.29
    3.45
    -23.18
    11.11
    -3.58
    Working Capital
    3
    17
    8
    4
    4
    4
    2
    -1
    - -
    3
    2
    -6
    -2
    1
    LT Debt
    1
    2
    3
    2
    2
    3
    1
    1
    1
    3
    2
    3
    1
    4
    Total Equity
    7
    23
    22
    18
    18
    11
    11
    10
    11
    14
    15
    7
    10
    9
    Return on Invested Capital (%)
    8.2
    12.99
    8.61
    - -
    1.03
    - -
    2.75
    - -
    5.37
    - -
    2.3
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    127.78
    - -
    - -
    - -
    - -
    -6.63
    3.1
    22.88
    - -
    - -
    - -
    - -

    Capital Structure

    USD

    •

    in mil. unless spec.
    Mar'03
    Jun'03
    Sep'03
    ST Debt
    5
    2
    1
    LT Borrowings
    1
    4
    4
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    6
    6
    6
    Market Capitalization
    1
    1
    3

    Working Capital

    USD

    •

    in mil. unless spec.
    Mar'03
    Jun'03
    Sep'03
    Total Current Assets
    8
    8
    7
    Cash, Cash Equivalents & STI
    3
    2
    2
    Accounts Receivable, Net
    4
    4
    4
    Inventories
    1
    1
    1
    Total Current Liabilities
    11
    7
    6
    Payables & Accruals
    5
    5
    4
    ST Debt
    5
    2
    1
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -2.19%
    8.35%
    53.74%
    Free Cash Flow
    -391.06%
    62.96%
    -97.61%
    Net Income, GAAP
    -1,099.2%
    -138.62%
    -139.43%
    Sales/Revenue/Turnover
    1.54%
    -4.63%
    -17.72%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    No data availableFinancial data will appear here once available

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    No data availableFinancial data will appear here once available

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    No data availableFinancial data will appear here once available

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • prnewswire.com

      PharmChem, Inc. Announces Shareholder Approval of Acquisition by Alcohol Monitoring Systems, Inc.

    • businesswire.com

      Shareholder Alert: The Ademi Firm Investigates Whether PharmChem, Inc. is Obtaining a Fair Price for its Public Shareholders

    • prnewswire.com

      Shareholder Alert: The Ademi Firm investigates whether PharmChem, Inc. is obtaining a Fair Price for its Public Shareholders

    • prnewswire.com

      PharmChem, Inc. Announces Acquisition by Alcohol Monitoring Systems, Inc.

    • prnewswire.com

      PharmChem, Inc. Announces Exploration of Strategic Alternatives